Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections

QJM: An International Journal of Medicine

Volumn 92, Issue 8, 1999, Pages 455-461

  Sheng, W H ^a   Hung, C C ^a   Chen, Y C ^a   Fang, C T ^a   Hsieh, S M ^a   Chang, S C ^a   Hsieh, W C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTITHYROID AGENT;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; BLOOD CULTURE; CAPNOCYTOPHAGA; CLINICAL ARTICLE; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; HYPERTHYROIDISM; INFECTION; KLEBSIELLA PNEUMONIAE; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SORE THROAT; STAPHYLOCOCCUS AUREUS; THYROID CRISIS; TONSILLITIS; URINARY TRACT INFECTION;

EID: 0032839123     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.8.455     Document Type: Article

References (32)

1. Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Safety 1996; 15:53-63.
2. Larsen PR, Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology, 9th edn. Philadelphia, WB Saunders, 1998:389-515.
3. Cooper DS. Antithyroid drugs. N Engl J Med 1984; 311:1353-62.
4. Cooper DS. Antithyroid drugs. In: Braverman LE, Utiger RD, eds. The Thyroid, 7th edn. Philadelphia, Lippincott, 1996:895-7.
5. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis: the usefulness of routine white blood cell count monitoring. Arch Intern Med 1990; 150:621-4.
6. Jones MK, Brouch KL, Allen MM, Aaron WS. In: St. Anthony's ICD-9-CM Code Book. International Classification of Diseases 9th Revision, Clinical Modification 4th edn. Alexandria, St. Anthony Publishing, 1991.
7. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
8. Li KL, Huang HS, Wang PW, Lin JD, JuangJH, Liu RT, Huang BY, Huang MJ. Agranulocytosis associated with antithyroid drugs in patients with Graves' thyrotoxicosis: report of 11 patients. Chang Gung Med J 1991; 14:168-73.
9. Hoffman DM, Burgess J, Hill P. Agranulocytosis and hepatic dysfunction following propylthiouracil treatment. Aust NZ J Med 1994; 24:409-10.
10. Freebairn RC, Young RJ, Gomersall CD, Wickham NWR, Critchley JAJH. Successful Treatment of carbimazole-induced agranulocytosis and severe sepsis with granulocyte macrophage colony stimulating factor. Anaesth Intens Care 1995; 23:510-12.
11. Oon CJ, Cheah JS. Successful treatment of severe carbimazole induced agranulocytosis by lithium carbonate. Singapore Med J 1978; 19:225-6.
12. Ryan ME, Morrissey JF. Typhlitis complicating methimazole-induced agranulocytosis. Gastrointest Endosc 1983; 29:299-302.
13. Hou GL, Tsai CC. Oral manifestations of agranulocytosis associated with methimazole therapy. J Periodontol 988; 59:244-8.
14. Magner JA, Snyder DK. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Thyroid 1994; 4:295-6.
15. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS. Adverse effects related to thionamide drug and their dose regimen. Am J Med Sci 1989; 297:216-19.
16. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-40.
17. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, Ridgway EC. Agranulocytosis associated with antithyroid drug: effects of patients age and drug dose. Ann Intern Med 1983; 98:26-9.
18. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab 1984; 58:863-72.
19. Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RHB, Falkenburg JHF. Agranulocytosis induced by propylthiotracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol 1986; 64:363-73.
20. Fincher ME, Fariss BL, Plymate SR, Jones RE, Messier MN. Agranulocytosis and a small dose of methimazole. Ann Intern Med 1984; 101:404-5.
21. Meyer-Gessner M, Benker G, Lederbogen S, Olbricht T, Reinwein D. Antithyroid drug-induced agranulocytosis. Clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest 1994; 17:29-36.
22. Pollack M. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn. New York, Churchill Livingstone, 1995:1980-2003.
23. Weinbren MJ, Forgeson G, Helenglass G, Jameson B, Powles R. Unusual presentation of Pseudomonas infection. Br Med J 1988; 297:1034-5.
24. Woods DE, Straus DC, Johanson WG Jr, Bass JA. Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest 1981; 68:1435-40.
25. Higuchi JH, Johanson WG Jr. The relationship between adherence of Pseudomonas aeruginosa to upper respiratory cells in vitro and susceptibility to colonization in vivo. J Lab Clin Med 1980; 95:698-705.
26. Woods DE, Straus DC, Johanson WG Jr, Berry VK, Bass JA. Role of pilli in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun 1980; 29:1146-51.
27. Schimpff SC, Greene WH, Young VM, Wiernik PH. Pseudomonas septicaemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer. Eur J Cancer 1973; 9:449-55.
28. Baltch A, Griffin PE. Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. Am J Med Sci 1977; 274:119-29.
29. Sobel R, Glick S. Monitoring antithyroid therapy. Arch Intern Med 1993; 153:2797.
30. Meletis J, Vavourakis S, Andreopoulos T. Recovery of carbimazole-induced agranulocytosis following recombinant granulocyte-macrophage colony stimulating factor (rh GM-CSF) administration. Haematologica 1993; 78:329-31.
31. Balkin MS, Buchholtz M, Oritiz J, Green AJ. Propyluracil (PTU) induced agranulocytosis treated with recombinant human granulocyte stimulating factor (G-CSF). Thyroid 1993; 3:305-9.
32. Adorf D, Grajer KH, Kaboth W, Nerl C. Agranulocytosis induced by antithyroid therapy: effect of treatment with granulocyte colony stimulating factor. Clin Investig 1994; 72:390-2.